Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

557
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
557
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

343
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
343
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

156
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
156
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

131
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
131
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

3.7K
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
3.7K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

593
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
593

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reliability of cancer screening questions from the National Health Interview Survey.

PloS one·2026
Same author

Measuring the validity of survey questions on breast, cervical, colorectal, and lung cancer screening.

American journal of epidemiology·2026
Same author

Developing indicators of risk to environmental variability based on species dependency in U.S. fishing communities in the Northeast and Southeast Regions.

PloS one·2025
Same author

Practice, beliefs and intent in influenza vaccination among Hispanic patients during the pandemic: An interventional study.

Vaccine·2025
Same author

Accuracy of self-reported exam indications for breast cancer screening.

JNCI cancer spectrum·2025
Same author

Protocol to measure validity and reliability of colorectal, breast, cervical and lung cancer screening questions from the 2021 National Health Interview Survey: Methodology and design.

PloS one·2024

Related Experiment Video

Updated: Dec 13, 2025

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

12.1K

Exercise Training in Patients With Heart Failure With Preserved Ejection Fraction: A Community Hospital Pilot Study.

Glenn Bean, Jin Mou, Bethann Pflugeisen

    The Journal of Cardiovascular Nursing
    |August 3, 2020
    PubMed
    Summary

    Community exercise training (ET) for heart failure with preserved ejection fraction (HFpEF) improved quality of life and exercise tolerance. This feasible and safe intervention warrants further investigation in larger trials.

    More Related Videos

    Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
    07:10

    Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

    Published on: August 24, 2019

    10.2K
    Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure
    04:20

    Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure

    Published on: October 1, 2019

    6.1K

    Related Experiment Videos

    Last Updated: Dec 13, 2025

    A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
    04:24

    A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

    Published on: April 19, 2019

    12.1K
    Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
    07:10

    Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

    Published on: August 24, 2019

    10.2K
    Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure
    04:20

    Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure

    Published on: October 1, 2019

    6.1K

    Area of Science:

    • Cardiology
    • Rehabilitation Medicine
    • Exercise Physiology

    Background:

    • Heart failure with preserved ejection fraction (HFpEF) significantly impairs exercise tolerance and quality of life.
    • Limited data exists on the feasibility and impact of exercise training (ET) for HFpEF patients in community hospital settings.

    Purpose of the Study:

    • To assess the feasibility and gather pilot data for a community-based HFpEF ET intervention.
    • To evaluate the preliminary effects of this intervention on patient outcomes.

    Main Methods:

    • A 9-week, single-group, pretest-posttest exercise training (ET) intervention was conducted with 16 participants.
    • Evaluations included the Minnesota Living With Heart Failure Questionnaire, Patient Health Questionnaire-9, cardiopulmonary exercise testing (peak VO2), and the 6-minute walk test.

    Main Results:

    • High adherence rates were observed, with 88% of prescribed ET sessions attended and 94% completion of assessments.
    • Significant improvements were noted in quality of life (P = .01), depressive symptoms (P ≤ .01), and exercise test duration (P = .01).
    • The 6-minute walk test also showed significant improvement (P = .001), though peak VO2 did not reach statistical significance (P = .16).

    Conclusions:

    • The community-based HFpEF ET intervention demonstrated feasibility and safety.
    • Findings suggest potential benefits for quality of life, depressive symptoms, and exercise tolerance in HFpEF patients.
    • Larger, controlled trials are recommended to further validate these preliminary results.